TransCode Therapeutics (RNAZ)
(Real Time Quote from BATS)
$11.31 USD
+0.20 (1.80%)
Updated Aug 7, 2025 11:32 AM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
RNAZ 11.31 +0.20(1.80%)
Will RNAZ be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for RNAZ based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RNAZ
All You Need to Know About TransCode Therapeutics (RNAZ) Rating Upgrade to Buy
RNAZ: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for RNAZ
12 Health Care Stocks Moving In Wednesday's Intraday Session
RNAZ Trading Temporarily Halted Due to Volatility Pause | RNAZ Stock News
Transcode Therapeutics (RNAZ) Resumes Trading Activity | RNAZ Stock News
Transcode Therapeutics Inc trading resumes
Transcode Therapeutics Inc trading halted, volatility trading pause